hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 21:48:09 - browse：74631

Matts Take Column Illustration — Molly Ferguson for STAT

What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of their suffering?

That question arises in the aftermath of a dramatic moment at the Food and Drug Administration last week. Over the FDA’s protests, a small biotechnology company called BrainStorm Cell Therapeutics had insisted that the agency evaluate its experimental treatment for amyotrophic lateral sclerosis, or ALS, brand named NurOwn. ALS patients made fervent pleas for the medicine, a type of stem cell preparation, based on reports on social media and re-analyses of the data that they thought indicated it might be of some help to those with the fatal disease.

But the FDA methodically dismantled BrainStorm’s application. The medicine couldn’t work the way the company said it would, the agency insisted; the clinical trials didn’t show it was effective; and it was not clear BrainStorm could manufacture the medicine with sufficient quality. Worst of all, more patients died among those who received the drug than those who got placebo. The FDA’s panel of expert advisers voted 17 to 1 that the medicine was not safe and effective, with one person abstaining. The agency doesn’t have to follow the panel’s advice but probably will.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： What Congress can do to address the rural doctor shortage

Wikipedia

WSS

Medical student insurance fails on mental health care coverage

It's been 20 years since Dolly the sheep. Where's my clone?

Intarcia’s device

NYC plans to house migrants on an island in the East River

Changes to biosimilar regulatory framework must prioritize patients

Experts study whether long Covid risk adds up with each reinfection

leisure time

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

At least 12 people were injured in a blast at a port in northwest Turkey

At least 13 dead in Texas as scorching temps continue

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Jerome Adams on the need for new antivirals for Covid

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Medical leaders decry Supreme Court decision on affirmative action

'The Exorcist' director William Friedkin dead at 87

Supreme Court strikes down use of affirmative action

Intarcia’s device

knowledge

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Changes to biosimilar regulatory framework must prioritize patients

Why workplace violence is so common in health care

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Wikipedia

Wikipedia

focus

focus